Clinical Practice Guideline - Asthma
||Date of Origin: April 1998
|Revised Date: November 2012
|Effective Date: December 2012
||Next Review Date: October
Regence supports the recommendations of the National Heart Lung and Blood Institute (NHLBI) and the contents of the July 2007 evidence report entitled Expert Panel Report 3: Guidelines for the Diagnosis and Treatment of Asthma (EPR-3).
Web Site Link:
National Heart, Lung and Blood Institute; located at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm
The NHLBI report is supported by Regence because it is based on scientific evidence, and where evidence is lacking, on panel consensus judgment. The report reflects the current standard of care.
- The panel members are recognized experts practicing in a variety of professional settings.
- Recommendations are based on a well-defined, comprehensive scientific literature search.
- Methods used to select appropriate scientific literature are well defined.
- The methods used to critically appraise the evidence supporting guideline recommendations are transparent.
- The guidelines clearly state the strength of the evidence on which recommendations are based.
- The panel considered 721 comments from 140 external reviewers (experts in the field and the general public) prior to finalizing and publishing the guideline.
- Sources of funding:
- Development of this report was entirely funded by NHLBI.
- Financial disclosures/potential conflict of interest statements for panel members are included in the evidence report.
- Some Regence members may be eligible for participation in the asthma disease management program. Please check benefits for eligibility.
- Asthma educational materials are included on the Regence website: myregence.com
Guideline Adoption and Recommended Use:
This guideline has been adopted based on nationally and locally recognized sources. This guideline is based on the most recent medical evidence at the time of the report or on a consensus of panel experts. Regence adopts guidelines to help practitioners and members make decisions about appropriate health care for specific conditions. Guidelines are not a substitute for professional medical advice.
Benefit determinations should be based in all cases on the applicable contract coverage. To the extent that there are any conflicts between these guidelines and the contract language, the contract language takes precedence.
Back to Index